Grant: Collaborative Health Research Projects
University of Waterloo
$143,361.00
Supervised in vivo lung perfusion strategy for treatment of cancer metastases to the lungs. Real time monitoring ofchemotherapy by on-site analytical platform
EF 2016-17
Résumé
Pulmonary metastases occur in approximately 30% of patients dying of cancer. The relatively poor results of surgicalresection of pulmonary metastases combined with intravenous systemic chemotherapy are probably due to drug resistanceand the inability to achieve effective drug concentrations within the lung. The proposed research aim to use method called invivo isolated lung perfusion (IVLP), which has the theoretical advantage of both selectively delivering an agent and divertingthe venous effluent. This allows a drug to be delivered in a higher dose, while drug levels in critical organs that are relativelysensitive to the drug, are kept low enough to avoid severe side effects. In order to optimize delivery of anticancer agent tothe isolated lungs, to monitor concentration of the drug and its distribution in the organ and finally to assess the effect of thedrug on the lungs the reliable analytical approach permitting rapid analysis and minimum invasiveness is required. For thispurpose we propose to use novel method called solid phase microextraction (SPME), the technology which utilizesmicroprobe coated with biocompatible polymer to be inserted directly into the tissue and extract small molecules with nonecessity of collection biopsy sample. It is postulated that due to the properties of the coating we can observe not only drugconcentration but also fast changes in metabolic profile of the organ as a response to the used chemotherapy in onesampling. We also propose to develop a strategy of coupling SPME with one of the mass spectrometry techniques enablingdetection of analytes in real time. This combination could be used as rapid intraoperative tool for monitoring ofdrug level and therapy progress.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
493734-2016
Name nom
Pawliszyn, Janusz
Department département
Chemistry
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
143361
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
3
Application title
Supervised in vivo lung perfusion strategy for treatment of cancer metastases to the lungs. Real time monitoring ofchemotherapy by on-site analytical platform
Keyword
NSERC
Application summary
Pulmonary metastases occur in approximately 30% of patients dying of cancer. The relatively poor results of surgicalresection of pulmonary metastases combined with intravenous systemic chemotherapy are probably due to drug resistanceand the inability to achieve effective drug concentrations within the lung. The proposed research aim to use method called invivo isolated lung perfusion (IVLP), which has the theoretical advantage of both selectively delivering an agent and divertingthe venous effluent. This allows a drug to be delivered in a higher dose, while drug levels in critical organs that are relativelysensitive to the drug, are kept low enough to avoid severe side effects. In order to optimize delivery of anticancer agent tothe isolated lungs, to monitor concentration of the drug and its distribution in the organ and finally to assess the effect of thedrug on the lungs the reliable analytical approach permitting rapid analysis and minimum invasiveness is required. For thispurpose we propose to use novel method called solid phase microextraction (SPME), the technology which utilizesmicroprobe coated with biocompatible polymer to be inserted directly into the tissue and extract small molecules with nonecessity of collection biopsy sample. It is postulated that due to the properties of the coating we can observe not only drugconcentration but also fast changes in metabolic profile of the organ as a response to the used chemotherapy in onesampling. We also propose to develop a strategy of coupling SPME with one of the mass spectrometry techniques enablingdetection of analytes in real time. This combination could be used as rapid intraoperative tool for monitoring ofdrug level and therapy progress.